Skip to main content
CBD Upstart Wages War On The $930 Billion Tobacco Giants
This company has created a new "CBD Cigarette" that has Big Tobacco scared. Their invention could steal market share from tobacco very quickly.

NYSE:CI - Cigna Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $272.53
  • Forecasted Upside: 0.72 %
  • Number of Analysts: 13
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 11 Buy Ratings
  • 1 Strong Buy Ratings
$270.59
▲ +9.41 (3.60%)
1 month | 3 months | 12 months
Get New Cigna Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CI and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CI

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$272.53
▲ +0.72% Upside Potential
This price target is based on 13 analysts offering 12 month price targets for Cigna in the last 3 months. The average price target is $272.53, with a high forecast of $315.00 and a low forecast of $236.00. The average price target represents a 0.72% upside from the last price of $270.59.
A Legal Cannabis Industry is Emerging From the Pot Stock Shadow
A paradigm shift is taking place right under your nose as investors ditch dicey pot stocks for a legal derivative of cannabis stirring up demand on a massive scale

Buy

The current consensus among 13 investment analysts is to buy stock in Cigna. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 1 strong buy ratings
  • 13 buy ratings
  • 2 hold ratings
  • 1 sell ratings
11/17/2019
  • 1 strong buy ratings
  • 14 buy ratings
  • 2 hold ratings
  • 1 sell ratings
2/15/2020
  • 1 strong buy ratings
  • 16 buy ratings
  • 2 hold ratings
  • 1 sell ratings
5/15/2020
  • 1 strong buy ratings
  • 16 buy ratings
  • 3 hold ratings
  • 1 sell ratings
8/13/2020
  • 1 strong buy ratings
  • 14 buy ratings
  • 3 hold ratings
  • 1 sell ratings
11/11/2020
  • 1 strong buy ratings
  • 11 buy ratings
  • 2 hold ratings
  • 0 sell ratings
2/9/2021
  • 1 strong buy ratings
  • 11 buy ratings
  • 2 hold ratings
  • 0 sell ratings
4/10/2021
  • 1 strong buy ratings
  • 11 buy ratings
  • 1 hold ratings
  • 0 sell ratings
5/10/2021

Latest Recommendations

  • 1 strong buy ratings
  • 11 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/10/2021Credit Suisse GroupBoost Price TargetOutperform$270.00 ➝ $300.00High
i
5/10/2021BMO Capital MarketsBoost Price TargetOutperform$300.00 ➝ $315.00High
i
5/10/2021MizuhoBoost Price TargetBuy$264.00 ➝ $290.00High
i
4/20/2021Truist SecuritiesBoost Price TargetBuy$280.00 ➝ $300.00Low
i
4/14/2021Truist FinancialBoost Price Target$280.00 ➝ $300.00Medium
i
4/14/2021Truist SecuritiesBoost Price TargetBuy$280.00 ➝ $300.00Low
i
3/9/2021TruistBoost Price Target$260.00 ➝ $280.00Low
i
3/9/2021BMO Capital MarketsBoost Price TargetOutperform$270.00 ➝ $290.00Low
i
3/9/2021MizuhoBoost Price TargetPositive ➝ Buy$229.00 ➝ $264.00Low
i
2/8/2021Morgan StanleyLower Price TargetOverweight$258.00 ➝ $254.00Low
i
2/5/2021CitigroupReiterated RatingBuy$273.00Medium
i
2/5/2021Deutsche Bank AktiengesellschaftLower Price TargetBuy$280.00 ➝ $270.00High
i
12/18/2020MizuhoBoost Price TargetBuy$220.00 ➝ $229.00High
i
12/14/2020SVB LeerinkBoost Price TargetMarket Perform$230.00 ➝ $240.00High
i
Rating by D. Ha at SVB Leerink LLC
11/11/2020Deutsche Bank AktiengesellschaftBoost Price TargetBuy$253.00 ➝ $280.00Low
i
11/11/2020Piper SandlerBoost Price TargetOverweight$234.00 ➝ $236.00Low
i
11/6/2020TruistBoost Price Target$240.00 ➝ $260.00Low
i
11/6/2020Raymond JamesBoost Price TargetStrong-Buy$240.00 ➝ $250.00Medium
i
11/6/2020SVB LeerinkBoost Price TargetMarket Perform$207.00 ➝ $230.00High
i
Rating by D. Ha at SVB Leerink LLC
8/3/2020Royal Bank of CanadaBoost Price TargetOutperform$266.00 ➝ $270.00Low
i
8/2/2020Royal Bank of CanadaReiterated RatingBuyLow
i
7/31/2020SVB LeerinkLower Price TargetMarket Perform$220.00 ➝ $207.00High
i
Rating by D. Ha at SVB Leerink LLC
7/1/2020SVB LeerinkInitiated CoverageMarket Perform$220.00Medium
i
Rating by S. Davis at SVB Leerink LLC
6/5/2020BMO Capital MarketsBoost Price TargetOutperform$215.00 ➝ $242.00High
i
6/5/2020UBS GroupLower Price TargetBuy$252.00 ➝ $246.00High
i
6/5/2020The Goldman Sachs GroupBoost Price TargetBuy$244.00 ➝ $264.00High
i
Rating by Stephen Tanal at The Goldman Sachs Group, Inc.
5/4/2020BarclaysLower Price TargetOverweight$232.00 ➝ $229.00Medium
i
5/4/2020Raymond JamesBoost Price TargetStrong-Buy$210.00 ➝ $240.00Low
i
5/4/2020Deutsche Bank AktiengesellschaftLower Price TargetBuy$288.00 ➝ $279.00Low
i
5/4/2020Sanford C. BernsteinDowngradeOutperform ➝ Market Perform$223.00Medium
i
5/1/2020Royal Bank of CanadaBoost Price TargetOutperform$249.00 ➝ $266.00High
i
4/13/2020Morgan StanleyBoost Price TargetOverweight$251.00 ➝ $258.00Low
i
4/13/2020SunTrust BanksLower Price TargetBuy$280.00 ➝ $240.00Medium
i
4/12/2020Royal Bank of CanadaReiterated RatingBuy$249.00Medium
i
3/27/2020Morgan StanleyBoost Price TargetOverweight$248.00 ➝ $251.00Low
i
3/24/2020Raymond JamesUpgradeOutperform ➝ Strong-BuyHigh
i
3/23/2020Raymond JamesLower Price TargetOutperform ➝ Outperform$240.00 ➝ $210.00High
i
2/25/2020Piper SandlerBoost Price TargetOverweight$236.00 ➝ $240.00High
i
2/18/2020Deutsche Bank AktiengesellschaftBoost Price TargetBuy$258.00 ➝ $288.00Low
i
Rating by George Hill at Deutsche Bank Aktiengesellschaft
2/10/2020BMO Capital MarketsReiterated RatingOutperform$252.00Low
i
Rating by Matthew Borsch at BMO Capital Markets
2/7/2020Evercore ISIInitiated CoverageHold$230.00Low
i
Rating by Michael Newshel at Evercore ISI
2/7/2020SunTrust BanksReiterated RatingBuy$280.00Low
i
2/7/2020Morgan StanleyBoost Price TargetOverweight$247.00 ➝ $248.00Medium
i
2/7/2020Raymond JamesBoost Price TargetOutperform$225.00 ➝ $240.00Medium
i
2/6/2020Cantor FitzgeraldReiterated RatingOverweight$245.00 ➝ $255.00Low
i
1/28/2020UBS GroupBoost Price TargetBuy$222.00 ➝ $244.00Low
i
1/27/2020The Goldman Sachs GroupReiterated RatingBuy$245.00Medium
i
Rating by Stephen Tanal at The Goldman Sachs Group, Inc.
1/23/2020CitigroupBoost Price TargetBuy$221.00 ➝ $263.00Low
i
Rating by Ralph Giacobbe at Citigroup Inc.
1/3/2020Raymond JamesUpgradeMarket Perform ➝ OutperformLow
i
1/2/2020StephensBoost Price TargetOverweight$242.00 ➝ $270.00Low
i
Rating by Scott Fidel at Stephens
12/23/2019CowenReiterated RatingBuy$250.00N/A
i
Rating by Charles Rhyee at Cowen Inc
12/20/2019JPMorgan Chase & Co.Boost Price TargetOverweight$225.00 ➝ $282.00High
i
12/19/2019Deutsche Bank AktiengesellschaftBoost Price TargetBuy$210.00 ➝ $229.00Low
i
Rating by George Hill at Deutsche Bank Aktiengesellschaft
12/11/2019Wells Fargo & CompanyDowngradeMarket Perform ➝ Underperform$181.00Medium
i
11/25/2019CowenReiterated RatingBuy$240.00Low
i
Rating by Charles Rhyee at Cowen Inc
11/6/2019MizuhoBoost Price TargetBuy$180.00 ➝ $205.00Medium
i
11/5/2019CitigroupReiterated RatingBuy$203.00 ➝ $221.00Low
i
Rating by Ralph Giacobbe at Citigroup Inc.
11/1/2019Deutsche Bank AktiengesellschaftSet Price TargetBuy$207.00 ➝ $210.00Medium
i
10/17/2019MizuhoInitiated CoverageBuy$180.00Medium
i
9/30/2019BMO Capital MarketsUpgradeMarket Perform ➝ Outperform$188.00Low
i
9/26/2019Morgan StanleyBoost Price TargetOverweight$207.00 ➝ $208.00High
i
Rating by Ricky Goldwasser at Morgan Stanley
9/12/2019Deutsche Bank AktiengesellschaftInitiated CoverageBuy$207.00High
i
9/10/2019OppenheimerSet Price TargetBuy$254.00High
i
Rating by Michael Wiederhorn at Oppenheimer Holdings Inc.
8/23/2019StephensSet Price TargetBuy$225.00High
i
Rating by Scott Fidel at Stephens
8/21/2019CitigroupReiterated RatingBuyMedium
i
Rating by Ralph Giacobbe at Citigroup Inc.
8/6/2019Sanford C. BernsteinUpgradeMarket Perform ➝ Outperform$205.00Low
i
8/2/2019Raymond JamesBoost Price TargetOutperform$185.00 ➝ $190.00Low
i
7/12/2019Morgan StanleyLower Price TargetOverweight$241.00 ➝ $207.00Low
i
6/3/2019CitigroupLower Price TargetBuy$228.00 ➝ $203.00Medium
i
5/3/2019The Goldman Sachs GroupDowngradeConviction-Buy ➝ BuyHigh
i
Rating by Stephen Tanal at The Goldman Sachs Group, Inc.
4/23/2019UBS GroupInitiated CoverageBuy ➝ Buy$185.00Medium
i
4/21/2019Cantor FitzgeraldReiterated RatingBuy$245.00Low
i
4/17/2019BarclaysLower Price TargetOverweight ➝ Overweight$220.00 ➝ $207.00Low
i
2/5/2019Morgan StanleyLower Price TargetOverweight ➝ Overweight$304.00 ➝ $299.00High
i
2/2/2019The Goldman Sachs GroupReiterated RatingBuyMedium
i
Rating by Stephen Tanal at The Goldman Sachs Group, Inc.
1/14/2019StephensInitiated CoverageOverweight$251.00Medium
i
1/7/2019Credit Suisse GroupReiterated RatingBuy$250.00Medium
i
1/6/2019BarclaysReiterated RatingBuy$220.00Low
i
1/3/2019Wells Fargo & CompanyLower Price TargetMarket Perform$221.00 ➝ $200.00Medium
i
1/3/2019Raymond JamesUpgradeMarket Perform ➝ Outperform$187.17Low
i
1/2/2019Edward JonesInitiated CoverageBuyMedium
i
Rating by John Boylan at Edward Jones
12/24/2018Edward JonesInitiated CoverageBuy ➝ Buy$181.30Low
i
12/13/2018Morgan StanleyInitiated CoverageOverweight$304.00Medium
i
11/19/2018SVB LeerinkBoost Price TargetOutperform ➝ Outperform$250.00 ➝ $260.00Low
i
11/2/2018BarclaysBoost Price TargetOverweight ➝ Overweight$228.00 ➝ $235.00N/A
i
11/2/2018CitigroupBoost Price TargetBuy ➝ Buy$243.00 ➝ $249.00N/A
i
11/2/2018BMO Capital MarketsBoost Price TargetMarket Perform ➝ Hold$220.00 ➝ $230.00Low
i
9/27/2018SunTrust BanksBoost Price TargetBuyLow
i
9/26/2018Cantor FitzgeraldInitiated CoverageOverweight$245.00Medium
i
Rating by S. Halper at Cantor Fitzgerald
9/21/2018SVB LeerinkBoost Price TargetOutperform$235.00 ➝ $250.00Low
i
9/18/2018Credit Suisse GroupBoost Price TargetOutperform$223.00 ➝ $237.00Medium
i
9/17/2018CowenInitiated CoverageOutperform$240.00High
i
8/3/2018SunTrust BanksBoost Price TargetBuy$244.00Low
i
8/3/2018Jefferies Financial GroupReiterated RatingBuy$224.00Low
i
6/6/2018The Goldman Sachs GroupUpgradeNeutral ➝ Buy$193.00 ➝ $212.00Medium
i
Rating by Stephen Tanal at The Goldman Sachs Group, Inc.
5/4/2018Credit Suisse GroupBoost Price TargetOutperform ➝ Outperform$215.00 ➝ $218.00N/A
i
3/13/2018Sanford C. BernsteinInitiated CoverageMkt Perform ➝ Market Perform$194.00Medium
i
Rating by Lance Wilkes at Sanford C. Bernstein
3/12/2018Credit Suisse GroupLower Price TargetOutperform ➝ Outperform$232.00 ➝ $215.00High
i
3/8/2018BarclaysInitiated CoverageOverweight ➝ Overweight$235.00High
i
2/2/2018OppenheimerBoost Price TargetOutperform$237.00Medium
i
2/2/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$255.00Low
i
1/3/2018The Goldman Sachs GroupInitiated CoverageNeutral ➝ Neutral$247.00Medium
i
11/3/2017CitigroupBoost Price TargetBuy$198.00 ➝ $231.00N/A
i
11/3/2017Morgan StanleyBoost Price TargetOverweight$195.00 ➝ $223.00N/A
i
11/3/2017Jefferies Financial GroupBoost Price TargetBuy$221.00 ➝ $231.00N/A
i
11/3/2017Royal Bank of CanadaReiterated RatingOutperform ➝ Outperform$185.00 ➝ $220.00N/A
i
11/2/2017Credit Suisse GroupInitiated CoverageOutperform$219.00N/A
i
10/16/2017BMO Capital MarketsInitiated CoverageMarket Perform$210.00N/A
i
10/13/2017Jefferies Financial GroupBoost Price TargetBuy$201.00 ➝ $221.00N/A
i
9/17/2017Piper Jaffray CompaniesReiterated RatingBuy$191.00Low
i
8/17/2017Morgan StanleyBoost Price TargetOverweight$188.00 ➝ $195.00Low
i
8/9/2017Royal Bank of CanadaReiterated RatingBuy$185.00High
i
8/7/2017CitigroupBoost Price TargetBuy$185.00 ➝ $198.00Low
i
8/7/2017Morgan StanleyBoost Price TargetOverweight$184.00 ➝ $188.00Low
i
8/7/2017Deutsche Bank AktiengesellschaftBoost Price TargetBuy$180.00 ➝ $190.00Low
i
8/4/2017Credit Suisse GroupReiterated RatingBuy$196.00High
i
8/4/2017Jefferies Financial GroupReiterated RatingBuy$199.00 ➝ $190.00Low
i
7/28/2017Piper Jaffray CompaniesReiterated RatingBuy$175.00Medium
i
7/24/2017Royal Bank of CanadaReiterated RatingBuy$182.00Low
i
7/14/2017Credit Suisse GroupReiterated RatingOutperform$190.00 ➝ $193.00Low
i
7/13/2017Deutsche Bank AktiengesellschaftBoost Price TargetBuy$175.00 ➝ $180.00Low
i
6/23/2017Bank of AmericaBoost Price TargetBuy$193.00 ➝ $198.00Medium
i
6/22/2017UBS GroupReiterated RatingBuy$186.00 ➝ $193.00N/A
i
6/22/2017Royal Bank of CanadaBoost Price TargetOutperform$177.00 ➝ $182.00Low
i
6/19/2017Wells Fargo & CompanyReiterated RatingMarket Perform$163.00 ➝ $174.00Low
i
6/15/2017CIBCBoost Price TargetOutperform$174.00 ➝ $185.00Medium
i
6/15/2017OppenheimerBoost Price TargetOutperform$174.00 ➝ $185.00Low
i
6/13/2017Royal Bank of CanadaReiterated RatingBuy$177.00Low
i
6/12/2017Credit Suisse GroupInitiated CoverageOutperform ➝ Outperform$185.00Low
i
6/8/2017Jefferies Financial GroupReiterated RatingBuy$183.00Medium
i
6/6/2017Morgan StanleyInitiated CoverageOverweight ➝ Overweight$184.00High
i
6/5/2017UBS GroupReiterated RatingBuy$181.00 ➝ $186.00N/A
i
6/1/2017CowenReiterated RatingOutperform$160.00 ➝ $185.00Low
i
5/15/2017Stifel NicolausBoost Price TargetBuy$170.00 ➝ $175.00N/A
i
5/15/2017Royal Bank of CanadaBoost Price TargetOutperform$172.00 ➝ $177.00N/A
i
5/15/2017Jefferies Financial GroupBoost Price TargetBuy$178.00 ➝ $183.00N/A
i
5/10/2017Deutsche Bank AktiengesellschaftBoost Price TargetBuy$172.00 ➝ $175.00Low
i
5/8/2017Royal Bank of CanadaBoost Price TargetOutperform ➝ Outperform$172.00 ➝ $177.00Medium
i
5/5/2017Jefferies Financial GroupReiterated RatingBuy$178.00 ➝ $183.00Medium
i
5/5/2017Stifel NicolausBoost Price TargetBuy$170.00 ➝ $175.00Low
i
4/23/2017Jefferies Financial GroupReiterated RatingBuy$172.00 ➝ $178.00Low
i
4/5/2017Deutsche Bank AktiengesellschaftInitiated CoverageBuy$172.00Low
i
3/13/2017Bank of AmericaInitiated CoverageBuy ➝ Buy$175.00Low
i
2/16/2017Royal Bank of CanadaUpgradeSector Perform ➝ Outperform$172.00N/A
i
2/10/2017Royal Bank of CanadaUpgradeSector Perform ➝ Outperform$172.00N/A
i
2/6/2017OppenheimerReiterated RatingOutperform$158.00 ➝ $164.00N/A
i
2/3/2017Royal Bank of CanadaReiterated RatingHold$151.00N/A
i
2/3/2017Jefferies Financial GroupReiterated RatingBuyN/A
i
1/23/2017CitigroupBoost Price TargetBuy$139.00 ➝ $163.00N/A
i
1/4/2017Piper Jaffray CompaniesInitiated CoverageOverweight$170.00N/A
i
11/7/2016Jefferies Financial GroupReiterated RatingBuy$153.00 ➝ $149.00N/A
i
10/16/2016Jefferies Financial GroupReiterated RatingBuy$153.00N/A
i
9/26/2016SVB LeerinkReiterated RatingBuy$155.00N/A
i
Rating by Ana Gupte at SVB Leerink LLC
9/22/2016Evercore ISIInitiated CoverageHold$134.00N/A
i
9/8/2016The Goldman Sachs GroupReiterated RatingBuy$160.00N/A
i
8/31/2016UBS GroupReiterated RatingBuyN/A
i
Rating by a.j. rice at UBS Group AG
8/31/2016William BlairReiterated RatingBuyN/A
i
8/23/2016Jefferies Financial GroupReiterated RatingBuyN/A
i
8/3/2016CitigroupLower Price TargetBuy$174.00 ➝ $146.00N/A
i
8/1/2016Jefferies Financial GroupLower Price TargetBuy$160.00 ➝ $153.00N/A
i
8/1/2016SVB LeerinkLower Price TargetOutperform$160.00 ➝ $155.00N/A
i
Rating by Ana Gupte at SVB Leerink LLC
7/22/2016UBS GroupReiterated RatingBuy$172.00 ➝ $152.00N/A
i
7/22/2016The Goldman Sachs GroupUpgradeBuy ➝ Conviction-Buy$170.00 ➝ $165.00N/A
i
7/14/2016UBS GroupReiterated RatingBuyN/A
i
7/8/2016OppenheimerReiterated RatingOutperform$149.00N/A
i
6/28/2016Wolfe ResearchInitiated CoverageOutperform$172.00N/A
i
6/28/2016Stifel NicolausInitiated CoverageBuy ➝ Buy$122.09 ➝ $169.00N/A
i
6/22/2016UBS GroupReiterated RatingBuy$172.00N/A
i
6/20/2016(FBRC)Reiterated RatingHoldN/A
i
Rating by Steven Halper at (FBRC)
6/15/2016SVB LeerinkReiterated RatingOutperform$155.00N/A
i
Rating by Ana Gupte at SVB Leerink LLC
6/1/2016BarclaysBoost Price TargetEqual Weight$156.00 ➝ $168.00N/A
i
5/18/2016Royal Bank of CanadaBoost Price TargetSector Perform$169.00 ➝ $174.00N/A
i
5/15/2016UBS GroupReiterated RatingBuy$172.00N/A
i
5/10/2016Jefferies Financial GroupReiterated RatingBuy$184.00 ➝ $165.00N/A
i
Rating by David Windley at Jefferies Financial Group Inc.
5/10/2016SVB LeerinkReiterated RatingOutperform$175.00N/A
i
Rating by Ana Gupte at SVB Leerink LLC
(Data available from 5/10/2016 forward)
Cigna logo
Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's U.S. Medical segment offers commercial products and services, including medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as Medicaid plans; and individual health insurance plans to on and off the public exchanges. Its International Markets segment offers health coverage, hospitalization, dental, critical illness, personal accident, term life, medical cost containment, and variable universal life products, as well as health care benefits to mobile employees of multinational organizations. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
Read More

Today's Range

Now: $270.59
$262.31
$272.77

50 Day Range

MA: $247.20
$238.25
$259.50

52 Week Range

Now: $270.59
$158.84
$263.67

Volume

69,527 shs

Average Volume

1,791,206 shs

Market Capitalization

$94.00 billion

P/E Ratio

18.98

Dividend Yield

1.53%

Beta

0.88

Frequently Asked Questions

What sell-side analysts currently cover shares of Cigna?

The following Wall Street research analysts have issued reports on Cigna in the last year: BMO Capital Markets, Citigroup Inc., Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, Mizuho, Morgan Stanley, Piper Sandler, Raymond James, Royal Bank of Canada, SVB Leerink LLC, The Goldman Sachs Group, Inc., Truist, Truist Financial Co., Truist Securities, UBS Group AG, and Zacks Investment Research.
View the latest analyst ratings for CI.

What is the current price target for Cigna?

15 Wall Street analysts have set twelve-month price targets for Cigna in the last year. Their average twelve-month price target is $272.53, suggesting a possible upside of 0.6%. BMO Capital Markets has the highest price target set, predicting CI will reach $315.00 in the next twelve months. Piper Sandler has the lowest price target set, forecasting a price of $236.00 for Cigna in the next year.
View the latest price targets for CI.

What is the current consensus analyst rating for Cigna?

Cigna currently has 1 hold rating, 11 buy ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe CI will outperform the market and that investors should add to their positions of Cigna.
View the latest ratings for CI.

What other companies compete with Cigna?

Other companies that are similar to Cigna include UnitedHealth Group, Anthem, Humana, Centene, Molina Healthcare, Magellan Health and Triple-S Management.

How do I contact Cigna's investor relations team?

Cigna's physical mailing address is 900 COTTAGE GROVE ROAD, BLOOMFIELD CT, 06002. The health services provider's listed phone number is 860-226-6000 and its investor relations email address is [email protected] The official website for Cigna is www.cigna.com.

This gold company is one to watch out for
This might be the biggest kept secret in finance, find out why industry experts are getting excited about this gold miner